Solid form analysis webinar series – coming soon
Nine months ago, my life changed when I became a mother.
Since that time, I’ve been on a rollercoaster of emotions and feelings. I feel happy, joyful, blessed, tired, but also worried sometimes. I worry when my son has a tummy ache, or when he catches a cold or has a fever following his vaccinations. When your child is sick, you must administer medicines to them. Even if they are in very small doses, but still … it makes you think!
My first thought in moments such as these is: “How great that there are established methods and routines for developing safe medicines and ensuring their quality!” It makes me consider the analytical techniques that are used, the critical material attributes (CMA) that must be defined, and the types of environment the medicines are produced in.
I never have any doubt about whether these pharmaceuticals might harm my baby. And I owe this certainty to the established process of pharmaceutical development, be that small molecule or biological pharmaceuticals. It makes me incredibly grateful for the scientific approaches that allow pharmaceutical companies to discover new active pharmaceutical ingredients (APIs) and develop formulations based on those APIs.
There is, of course, a whole process behind the development of a new drug product. I am proud that Malvern Panalytical provides support to pharmaceutical companies to develop these new medicines. You can find an overview of these technologies and services, and where they support the development workflow for small molecule applications, in this Pharmaceutical Toolkit (to view the Toolkit, click “Download brochure”).
Solid form analysis in early API development
These thoughts also motivate me to share how the field I work in, X-ray diffraction (XRD), is contributing to making pharmaceutical products safe. To that end, I will be presenting a short webinar series dedicated to the most important aspects of XRD in pharmaceutical environment. We will:
- Explain the regulatory guidance
- Walk through method development
- Describe the role of XRD applications in early and late development stages
- Define the requirements for robust Quality Control (GMP)
- Reveal the key attributes of a reliable regulated environment solution
- Demonstrate a suite of analysis approaches to get the most out of XRD data
Want to learn more? Join us for these live events in our Solid form analysis webinar series:
- Solid form analysis: why it’s essential for API development! – November, 1
- Solid form analysis: Quick and accurate candidate selection – November 22
- Solid form analysis: Get up close and personal with your API – December 8
Watch this space for further events, coming in 2023!